Partner Headlines - BIIB

  1. Earnings Scheduled For January 29, 2015

    Benzinga
  2. Biotech Stocks Down Despite Strong Amgen Quarter

    IBD
  3. Stocks Fade Badly; EA Hangs Tough

    IBD
  4. Earnings Scheduled For January 28, 2015

    Benzinga
  5. Must Watch Stocks for January 28, 2015

    Benzinga
  6. Big Cap Stocks Mylan, American Tower Near Buy Points

    IBD
  7. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga
  8. Apple, Facebook Lead This Week's IBD 50 Earnings

    IBD
  9. Apple, Facebook Lead Top IBD 50 Earnings This Week

    IBD
  10. IBD 50 Turns In Solid Week As Market Uptrend Resumes

    IBD
  11. The 5 Biggest Biotech Stocks

    Benzinga
  12. Jefferies 'Encouraged' By Biogen Idec's New Data

    Benzinga
  13. Nomura's Takeways From Biogen Idec's Analyst Meeting

    Benzinga
  14. Biogen Idec To Acquire Convergence Pharmaceuticals In Deal Worth ...

    Benzinga
  15. Meet 5 Top Medical Stocks Making Waves This Week

    IBD
  16. Stocks Turn Negative; Goodyear Triggers Sell Signal

    IBD
  17. A Look At 3 Biotech Stocks With Upside Potential

    Benzinga
  18. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  19. Stocks Reverse Lower On Good News/Bad News Job Data

    IBD
  20. Biogen drug results mixed

    IBD
  21. Nasdaq, S&P 500 Gap Up At Open, Hold Strong Gains

    IBD
  22. Biogen Nerve-Repair Drug Yields Mixed Results

    IBD
  23. Stock Market Surges; Nasdaq, S&P 500 Retake 50-Day Lines

    IBD
  24. Stocks Poised For Early Pop; Global Payments Gains

    IBD
  25. Stock Indexes Gun For Best Pop In 3 Weeks; Monster Breaks Out

    IBD
  26. Late-Session Rally Fades; Stocks End Firmly Lower

    IBD
  27. Oil's Drop Spooks Market Again, But REITs Outperform

    IBD
  28. Stocks Take It On The Chin Again; 10-Year Yield Plummets

    IBD
  29. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus
  30. What Investors Are Looking For In NPS Pharmaceuticals Ahead Of ...

    Benzinga
  31. Benzinga's Top Initiations

    Benzinga
  32. Barclays Initiates Biogen Idec At Overweight

    Benzinga
  33. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD
  34. Isis Pharma To Develop GI Drugs With J&J

    IBD
  35. An Investor's Guide: Market-Leading Industries In 2014

    IBD
  36. Stocks Reverse Lower; Apple Plunges Below Support

    IBD
  37. Stocks Surrender Early Gains, But Chip Stocks Outperform

    IBD
  38. 5 Biotech Stocks With Big News Due In January

    IBD
  39. Will 2015 Be Different For Big Cap Stocks?

    IBD
  40. Are There Any Winners Left In The Biotech Space?

    Benzinga
  41. How Gilead And Johnson & Johnson's Tumble Affected These Hedge ...

    Benzinga
  42. Fresh Milestones For Dow, S&P 500 But Biotechs Hit

    IBD
  43. Toys, Department Stores Rock, But Biotechs Tumble

    IBD
  44. Indexes Turn Mixed On Data; Celgene Dives

    IBD
  45. Express Scripts Picks AbbVie HCV Drugs Over Gilead

    IBD
  46. Broad Indexes Little Changed; Facebook Breaks Out

    IBD
  47. Stocks Struggle To Hold Gains; Alaska Air, Spirit Up

    IBD
  48. Morning Market Losers

    Benzinga
  49. Benzinga's Top #PreMarket Losers

    Benzinga
  50. Stocks Press Higher; Biotechs Gilead, Biogen Rise

    IBD
  51. Roche Drugs For Alzheimer's, Breast Cancer Disappoint

    IBD
  52. Juiced By Fed, Stocks Rocket Higher; Biogen Up 6%

    IBD
  53. Stocks Hold Near Session Highs; FedEx Bounces Back

    IBD
  54. Meet 5 Top Biotech Stocks Holding Up In Shaky Market

    IBD
  55. United Therapeutics: Will It Pass Peers In 2015?

    IBD
  56. Lilly Upgraded On 2 Potential Blockbuster Drugs

    IBD
  57. The Biotech Stock With The Most Upside In 2015, According To ...

    Benzinga
  58. Pfizer Spreading Its Wings Into A New Domain Of Life Sciences

    GuruFocus
  59. 3 Biotech ETFs Rally On Merger News

    Benzinga
  60. Hot Drugmakers Build More Labs, Grab Space In Boston

    IBD
  61. Will New Alzheimer's Drug Boost Biogen?

    IBD
  62. Stock Market Today: Stocks Worsen Near Midday; Airlines Rally

    IBD
  63. Biogen's Alzheimer's Drug Moves to Phase III

    GuruFocus
  64. Stock Market Today: Indexes Close Near Day's Highs

    IBD
  65. Great News For Biogen, But What's Next For The Stock?

    Benzinga
  66. Biogen Drug Test Advances

    IBD
  67. Stock Market Today: Indexes Trade Near Session Highs

    IBD
  68. Deutsche Bank Sees More Upside For Biogen

    Benzinga
  69. Biogen Alzheimer's Drug Succeeding In Early Tests

    IBD
  70. Here's Why Biogen Shares Soared Today

    Benzinga
  71. Stock Market Today Opens Higher; FedEx, Biogen, Cypress Surge

    IBD
  72. Biogen Up Sharply On Promising Alzheimer's Results

    Benzinga
  73. Novartis' MS drug fails trial

    IBD
  74. Novartis' Gilenya Fails To Treat Progressive MS

    IBD
  75. FDA Orders New Label For Biogen Idec's MS Drug

    Benzinga
  76. UPDATE: Credit Suisse Reiterates On Biogen Idec On Gilenya PPMS ...

    Benzinga
  77. Biotech Stocks Hit: Stock Market To See New Leaders?

    IBD
  78. Stocks Drift Lower As Biotechs Tumble

    IBD
  79. Stocks Mixed; Amazon Jumps On Book Deal

    IBD
  80. The Bull/Bear Breakdown On Biogen Idec

    Benzinga
  81. Gilead Sciences Releases Impressive Results for Hepatitis C Drug

    GuruFocus
  82. Energy Stocks: Cash Metric Flashes “Oversold”

    YCharts
  83. Shire CEO Looks Ahead To Independent Future

    IBD
  84. Three Attractively Priced Small Cap Biotech Stocks

    GuruFocus
  85. These 5 Drugmakers' Earnings Excelled This Quarter

    IBD
  86. Citi, Jefferies Weigh In On Biogen Idec Amid Q3 Earnings

    Benzinga
  87. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  88. Leading Researchers Join Biogen Idec To Advance Drug Discovery ...

    Benzinga
  89. Better Biotechs Don't Satisfy

    IBD
  90. Biotechs Show Fed Chief's Not Much Of A Stock Analyst

    IBD
  91. Markets Reverse Early Morning Gains Following Canadian Shooting

    Benzinga
  92. Major Indexes End Win Streak; Super Micro Surges

    IBD
  93. Stocks Erase Modest Gains; Apple Flirts With Breakout

    IBD
  94. Stocks Up at Midday; Super Micro Retakes Buy Point

    IBD
  95. Biogen, Thermo Reports Disappoint; Abbott Accelerates

    IBD
  96. Stocks Cling To Slender Advance; Boeing, Cree, Biogen Slide

    IBD
  97. Morning Market Losers

    Benzinga
  98. Benzinga's Top #PreMarket Losers

    Benzinga
  99. UPDATE: Biogen Idec Posts Upbeat Q3 Results, Raises Earnings ...

    Benzinga
  100. Earnings Scheduled For October 22, 2014

    Benzinga
Trading Center